BioArctic AB/Skr BIOA B
07:00
03:05
23:15
19:20
15:25
1D1W1MYTD1Y5YMAX
About BioArctic AB
BioArctic AB is a Swedish biopharmaceutical company focusing on developing treatments for central nervous system disorders. The company is notably engaged in the research and development of therapies for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Founded in 2003, BioArctic collaborates with academic institutions and global pharmaceutical companies to advance its innovative approaches. The company is headquartered in Stockholm, Sweden, and leverages its strategic partnerships and scientific expertise to address unmet medical needs in its chosen field. BioArctic's competitive strengths include its proprietary technology platforms and strong intellectual property portfolio.
Ticker
Skr BIOA B
Sector
Primary listing
XSTO
Employees
141
Headquarters
Stockholm, Sweden
Website
BioArctic AB Metrics
BasicAdvanced
kr 26bn
124.21
kr 2.40
-0.78
kr 2.00
0.67%
Price and volume
Market cap
kr 26bn
Beta
-0.78
52-week high
kr 364.40
52-week low
kr 174.50
Average daily volume
210k
Dividend rate
kr 2.00
Financial strength
Current ratio
6.538
Quick ratio
5.123
Long term debt to equity
1.139
Total debt to equity
1.853
Profitability
Gross margin (TTM)
94.13%
Net profit margin (TTM)
18.59%
Operating margin (TTM)
43.14%
Effective tax rate (TTM)
48.46%
Revenue per employee (TTM)
kr 8,140,000
Management effectiveness
Return on assets (TTM)
12.88%
Return on equity (TTM)
10.32%
Valuation
Price to earnings (TTM)
124.213
Price to revenue (TTM)
23.015
Price to book
11.94
Price to tangible book (TTM)
11.94
Price to free cash flow (TTM)
21.239
Free cash flow yield (TTM)
4.71%
Free cash flow per share (TTM)
14.031
Dividend yield (TTM)
0.67%
Forward dividend yield
0.67%
Growth
Revenue change (TTM)
-24.40%
Earnings per share change (TTM)
-76.43%
3-year revenue growth (CAGR)
22.85%
3-year earnings per share growth (CAGR)
-13.30%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs